| S.N. |
PRODUCT NAME |
CAS NO |
QTY/MONTH |
| 01 |
Telmisartan & Intermediates |
144701-48-4 |
2 |
| 4’-methylbiphenyl – 2- carbonitrile (Stage – A) |
114772-53-1 |
| 4-Bromomethyl 2-cyano biphenyl (Stage – B) |
114772-54-2 |
| 4'-[[4-methyl-6-(1-methyl-1H-benzimidazol-2-yl)-2-propyl-1H-benzimidazol- 1-yl] biphenyl-2-carbonitrile.(Stage – C) |
144702-27-2 |
| 4'-[[4-Methyl-6-(1-methyl-2-benzimidazole)-2-propyl-1-benzimidazol -1-yl] methyl] biphenyl-2-carboxylic acid. (Stage - Final) |
144701-48-4 |
| [S-fluoromethyl 6a,9a-difluoro 11β-hydroxy-16 α-Methyl- 17 α(propionyloxy)-3-oxondrosta-1,4-diene 17 β-carbothioate](Stage – E) |
80474-14-2 |
| [S-fluoromethyl 6a,9a-difluoro 11β-hydroxy-16 α-Methyl- 17 α(propionyloxy)-3-oxondrosta-1,4-diene 17 β-carbothioate](Stage – Final) |
80474-14-2 |
| 02 |
Pentaprazole sodium & Intermediates |
138786-67-1 |
3 |
| (RS)-6-(Difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]-1H-benzo[d]imidazole(Stage – A) |
102625-64-9 |
| (RS)-6-(Difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]-1H-benzo[d]imidazole(Stage – Final) |
164579-32-2 |
| 03 |
Atorvastatin & Intermediates |
134523-00-5 |
1.5 |
| (4R,6R)-tert-Butyl-6-(2-aminoethyl)-2,2-dimethyl-1,3-dioxane-4-acetate |
125995-13-3 |
| tert-Butyl (4R,6R)-2-[[[6-(2-4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrol-1-yl]ethyl]-2,2-dimethyl-1,3-dioxan-4-yl]acetate |
125971-95-1 |
| [R-(R*, R*)]-2-(4-fluorophenyl)-β, δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1Hpyrrole-1-heptanoic acid, calcium salt (2:1)trihydrate. |
134523-03-8 |
| (3R)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one;phosphoric acid;hydrate(Stage – Final) |
654671-77-9 |
| 04 |
Etoricoxib & Intermediates |
134523-00-5 |
2 |
| 1-(6-Methyl-3-pyridinyl)-2-(4-methyl sulfonyl)phenyl-ethanone(Ketosulphone, stage – A) |
221615-75-4 |
| 5-chloro-6'-methyl-3-[4-(methylsulfonyl)phenyl]-2,3'-bipyridine (Stage – Final) |
202409-33-4 |
| 05 |
Lornoxicam & Intermediates |
70374-39-9 |
0.5 |
| 6-chloro-4-hydroxy-3- Methoxycarbonyl-2H-Thieno[2,3,e]-1,2-Thiazine-1,1-Dioxide(Stage –A) |
70374-51-5 |
| 6-chloro-4-hydroxy-2-methyl-3-Methoxycarbonyl-2H-Thieno [2,3,e]-1,2-Thiazine-1,1-Dioxide(Stage – B) |
70415-50-8 |
| 6-chloro-4-hydroxy-2-methyl-N-(2-pyridinyl)-2H-thieno[2,3,e]-1,2-Thiazine-3-carboxamide- 1,1-dioxide(Stage – C) |
70374-39-9 |
| 6-chloro-4-hydroxy-2-methyl-N-(2-pyridinyl)-2H-thieno[2,3,e]-1,2-Thiazine-3-carboxamide- 1,1-dioxide(Stage – Final) |
70374-39-9 |
| 06 |
Phenyl ephrine HCl & Intermediates |
61-76-7 |
2.5 |
| 2-bromo-1-(3-hydroxyphenyl)ethanone(Stage - A) |
2491-37-4 |
| 2-[benzyl(methyl)amino]-1-(3-hydroxyphenyl)ethanone(stage – B) |
56917-44-3 |
| 3-[1-hydroxy-2-(methylamino)ethyl]phenol(Stage – C) |
1477-63-0 |
| 1R)-1-(3-Hydroxyphenyl)-2-(methylamino)ethanol hydrochloride(Stage – Final) |
61-76-7 |
| 07 |
Glimepiride |
93479-97-1 |
1 |
| 08 |
Voriconazole |
137234-62-9 |
2 |
|
INTERMEDIATE PRODUCT |
|
|
| 9 |
OXYCLOZANIDE |
2277-92-1 |
15 |
| 10 |
PYROXICAM |
36322-90-4 |
| 11 |
TIZANIDINE |
51322-75-9 |
| 12 |
N-Butyl Bromide |
149-64-4 |
| 13 |
N-Propyl Bromide |
106-94-5 |
| 14 |
Chlorhexidine |
55-56-1 |
| 15 |
chlorhexidine gluconate |
18472-51-0 |
| 16 |
Bis(2-chloroethyl)amine hydrochloride |
821-48-7 |
| 17 |
Methyl 3-aminocrotonate |
14205-39-1 |
| 18 |
Methyl acetate |
79-20-9 |
| 19 |
Para-Toluenesulfonic acid |
104-15-4 6192-52-5 |
| 20 |
3'-Hydroxypropiophenone |
13103-80-5 |
| 21 |
3'-methoxypropiophenone |
37951-49-8 |
| 22 |
Meta Bromo Nitrobenzene |
585-79-5 |
| 23 |
4-(2-Chloroethyl)morpholine Hydrochloride |
3647-69-6 |
| 24 |
Cetylpyridinium chloride |
123-03-5 6004-24-6 |
| 25 |
Lauroyl chloride |
112-16-3 |
| 26 |
4 AMINO 1-2-4 TRIAZOLE |
584-13-4 |
| 27 |
1 H 1-2-4 TRIAZOLE |
288-88-0 |
